AI assistant
Sending…
Royalty Pharma plc — Director's Dealing 2022
Jun 23, 2022
30286_dirs_2022-06-23_e8de62e4-e5bb-4b0b-9984-aadedf67f7e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2022-06-23
Reporting Person: HODGSON DAVID C (Director)
More from Royalty Pharma plc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13